Churg-Strauss syndrome epidemiology and demographics: Difference between revisions
(→Race) |
|||
| Line 7: | Line 7: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million persons per year.<ref name="pmid14872461">{{cite journal| author=Mahr A, Guillevin L, Poissonnet M, Aymé S| title=Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. | journal=Arthritis Rheum | year= 2004 | volume= 51 | issue= 1 | pages= 92-9 | pmid=14872461 | doi=10.1002/art.20077 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14872461 }} </ref> | The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million persons per year.<ref name="pmid14872461">{{cite journal| author=Mahr A, Guillevin L, Poissonnet M, Aymé S| title=Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. | journal=Arthritis Rheum | year= 2004 | volume= 51 | issue= 1 | pages= 92-9 | pmid=14872461 | doi=10.1002/art.20077 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14872461 }} </ref><ref name="pmid254049302">{{cite journal| author=Gioffredi A, Maritati F, Oliva E, Buzio C| title=Eosinophilic granulomatosis with polyangiitis: an overview. | journal=Front Immunol | year= 2014 | volume= 5 | issue= | pages= 549 | pmid=25404930 | doi=10.3389/fimmu.2014.00549 | pmc=4217511 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25404930 }}</ref> | ||
===Incidence=== | ===Incidence=== | ||
The incidence of Eosinophilic granulomatosis with polyangiitis ranges from 0.5 to 6.8 per million persons per year. | The incidence of Eosinophilic granulomatosis with polyangiitis ranges from 0.5 to 6.8 per million persons per year.<ref name="pmid25404930">{{cite journal| author=Gioffredi A, Maritati F, Oliva E, Buzio C| title=Eosinophilic granulomatosis with polyangiitis: an overview. | journal=Front Immunol | year= 2014 | volume= 5 | issue= | pages= 549 | pmid=25404930 | doi=10.3389/fimmu.2014.00549 | pmc=4217511 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25404930 }}</ref> | ||
==Demographics== | ==Demographics== | ||
The rate distribution of Eosinophilic granulomatosis with polyangiitis varies upon age, sex, and race. | The rate distribution of Eosinophilic granulomatosis with polyangiitis varies upon age, sex, and race. | ||
Revision as of 16:51, 10 March 2017
|
Churg-Strauss syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Churg-Strauss syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Churg-Strauss syndrome epidemiology and demographics |
|
Churg-Strauss syndrome epidemiology and demographics in the news |
|
Blogs on Churg-Strauss syndrome epidemiology and demographics |
|
Risk calculators and risk factors for Churg-Strauss syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]
Overview
The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million persons per year, with higher prevalences seen in Europeans.[1]
Epidemiology and Demographics
Prevalence
The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million persons per year.[1][2]
Incidence
The incidence of Eosinophilic granulomatosis with polyangiitis ranges from 0.5 to 6.8 per million persons per year.[3]
Demographics
The rate distribution of Eosinophilic granulomatosis with polyangiitis varies upon age, sex, and race.
Age
The mean age of diagnosis of Eosinophilic granulomatosis with polyangiitis is 48 years of age. The incidence of the disease in female patients is between the ages of 14 to 74 years of age. The age for males is comparable to that of female patients with the disease.
Gender
There is no sex predominance for Eosinophilic granulomatosis with polyangiitis. [4]
Race
The race most commonly affected by Eosinophilic granulomatosis with polyangiitis is poorly documented. However, prevalence of the disease is seen both in Asian and European populations with an equal distribution.[5]
References
- ↑ 1.0 1.1 Mahr A, Guillevin L, Poissonnet M, Aymé S (2004). "Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate". Arthritis Rheum. 51 (1): 92–9. doi:10.1002/art.20077. PMID 14872461.
- ↑ Gioffredi A, Maritati F, Oliva E, Buzio C (2014). "Eosinophilic granulomatosis with polyangiitis: an overview". Front Immunol. 5 ( ): 549. doi:10.3389/fimmu.2014.00549. PMC 4217511. PMID 25404930.
- ↑ Gioffredi A, Maritati F, Oliva E, Buzio C (2014). "Eosinophilic granulomatosis with polyangiitis: an overview". Front Immunol. 5 ( ): 549. doi:10.3389/fimmu.2014.00549. PMC 4217511. PMID 25404930.
- ↑ Mouthon L, Dunogue B, Guillevin L (2014). "Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome)". J Autoimmun. 48-49 ( ): 99–103. doi:10.1016/j.jaut.2014.01.018. PMID 24530234.
- ↑ Gibelin A, Maldini C, Mahr A (2011). "Epidemiology and etiology of wegener granulomatosis, microscopic polyangiitis, churg-strauss syndrome and goodpasture syndrome: vasculitides with frequent lung involvement". Semin Respir Crit Care Med. 32 (3): 264–73. doi:10.1055/s-0031-1279824. PMID 21674413.